January 6, 2021 (Source) — StageZero Life Sciences (TSX:SZLS), a company dedicated to the early detection of cancer and multiple disease states through whole blood, today announced that it will be presenting at the SNN Network Canada Virtual Event on Thursday January 7, 2021 at 8am EST. James Howard-Tripp, Chairman and CEO will be hosting the presentation and answering questions from investors.
To access the live presentation, please use the following information:
SNN Network Canada Virtual Event 2021
Date: Thursday, January 7, 2020
Time: 8am Eastern Time (5am Pacific Time)
If you would like to book 1on1 investor meetings with StageZero Life Sciences, and to watch StageZero’s presentation, please make sure you are registered for the virtual event here: https://canada.snn.network/signup
1on1 meetings will be scheduled and conducted via private, secure video conference through the conference event platform.
The SNN Network Canada Virtual Event website is available here: https://canada.snn.network/
If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: https://canada.snn.network/agenda
News Compliments of ACCESSWIRE
About StageZero Life Sciences, Ltd.
StageZero Life Sciences is dedicated to the early detection of multiple disease states through whole blood. The Company operates a CAP accredited and CLIA certified high complexity reference laboratory based in Richmond, Virginia. A specialist in PCR testing for the early identification of Cancer through blood, the Company is uniquely positioned to provide both COVID PCR testing (swab) and blood test analysis (Antibody testing). Our full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups. As we provide COVID-19 testing during this Pandemic, we continue making progress with our mission to eradicate late-stage cancers through early detection. Our next generation test, Aristotle®, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. www.stagezerolifesciences.com
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU’RE interested in; find out about investor conferences YOU want to attend – all here on SNN.Network.
If you would like to attend the SNN Network Virtual Investor Conference, please register here: https://conference.snn.network/signup
Tel: 1-855-420-7140 Ext. 1838
SOURCE: StageZero Life Sciences via SNN Network